Literature DB >> 879407

Criteria for selection of patients for emergency portacaval shunt.

M J Orloff, L R Duguay, L D Kosta.   

Abstract

A computer program analysis of the effect on survival of 74 preoperative factors was performed as part of a prosepctive study of the emergency portacaval shunt in 146 unselected patients with bleeding esophageal varices due to alcoholic cirrhosis. Only ascites, a serum glutamic oxalacetic transaminase level of 100 units or more, and a requirement for 5,000 ml or more of blood transfusion were associated with a statistically significant decrease in survival. However, none of these factors are contraindications to operation because their presence permits a survival rate of 37 to 40%. The only contraindication to emergency portacaval shunt is the combined presence of ascites, jaundice, encephalopathy, and severe muscle wasting, a constellation that was incompatible with survival beyond one year.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 879407     DOI: 10.1016/0002-9610(77)90298-7

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  13 in total

1.  General surgery-epitomes of progress: portal hypertension.

Authors:  R A Crass
Journal:  West J Med       Date:  1980-12

2.  A comparative pharmacokinetic study of conventional propranolol and long acting preparation of propranolol in patients with cirrhosis and normal controls.

Authors:  R G Watson; W Bastain; K A Larkin; J R Hayes; J A McAinsh; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1987-10       Impact factor: 4.335

3.  Portal pseudoperfusion: an angiographic illusion.

Authors:  J T Fulenwider; B M Nordlinger; W J Millikan; P J Sones; W D Warren
Journal:  Ann Surg       Date:  1979-03       Impact factor: 12.969

Review 4.  Portacaval shunts.

Authors:  A D Callow
Journal:  World J Surg       Date:  1984-10       Impact factor: 3.352

5.  The role of cardiovascular hemodynamics and liver histology in evaluating bleeding cirrhotic patients.

Authors:  V Dicarlo; C Staudacher; R Chiesa; B Andreoni; M Cristallo; E Ronchetti
Journal:  Ann Surg       Date:  1979-08       Impact factor: 12.969

6.  Hemodynamic patterns in human hepatic cirrhosis: a prospective randomized study of the hemodynamic sequelae of distal splenorenal (Warren) and mesocaval shunts.

Authors:  F A Reichle; O E Owen
Journal:  Ann Surg       Date:  1979-10       Impact factor: 12.969

7.  Emergency portacaval shunt versus rescue portacaval shunt in a randomized controlled trial of emergency treatment of acutely bleeding esophageal varices in cirrhosis--part 3.

Authors:  Marshall J Orloff; Jon I Isenberg; Henry O Wheeler; Kevin S Haynes; Horacio Jinich-Brook; Roderick Rapier; Florin Vaida; Robert J Hye
Journal:  J Gastrointest Surg       Date:  2010-07-24       Impact factor: 3.452

8.  Physiologic determinants of operative survival after portacaval shunt.

Authors:  K Waxman; W C Shoemaker
Journal:  Ann Surg       Date:  1983-01       Impact factor: 12.969

9.  Impact of preshunt liver histology on survival following portasystemic shunt surgery for bleeding esophageal varices.

Authors:  J H Grendell; J P Cello; W Margaretten; D C Heilbron
Journal:  Dig Dis Sci       Date:  1983-01       Impact factor: 3.199

10.  Long-term results of emergency portacaval shunt for bleeding esophageal varices in unselected patients with alcoholic cirrhosis.

Authors:  M J Orloff; R H Bell; P V Hyde; W P Skivolocki
Journal:  Ann Surg       Date:  1980-09       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.